Umbilical cord blood (UCB) stem cells have gained much significance in medical science owing to their ability to transform into any type of human cells. UCB refers to the blood that remains in the attached umbilical cord and placenta after childbirth. Stem cells that UCB contains are considered unique in their applicability in treating several life-threatening diseases. UCB stem cells are also used to treat genetic and hematopoietic disorders.
Increase in the prevalence rate of chronic diseases such as cancer, diabetes, blood disease, immune disease, metabolic disease etc. Has increased the need of cost effective and efficient way of treatment. However, cord blood stem cells have the potential to treat these chronic diseases effectively. These stem cells have special property of higher cell count in lower blood volume. Collection of these stem cells is much easier than other stem cells and could be stored in specialized preservation facilities called as Cord Blood Stem Cell Banks.

Market Analysis and Insights: Global Stem Cell Umbilical Cord Blood Market
The global Stem Cell Umbilical Cord Blood market size is projected to reach US$ 129860 million by 2027, from US$ 19020 million in 2020, at a CAGR of 31.0% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Stem Cell Umbilical Cord Blood market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Stem Cell Umbilical Cord Blood market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Stem Cell Umbilical Cord Blood market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Stem Cell Umbilical Cord Blood market.

Global Stem Cell Umbilical Cord Blood Scope and Market Size
Stem Cell Umbilical Cord Blood market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Stem Cell Umbilical Cord Blood market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Public Cord Blood Banks
Private Cord Blood Banks

Segment by Application
Cancer/ Oncology Diseases
Chronic Leukemia
Myelodysplastic Syndrome
Blood Diseases
Beta Thalassemia
Sickle Cell Disease
Wiskott-Aldrich
Hurler Syndrome
Sanfilippo Syndrome

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Advanced Cell Technology
California Stem Cell
Cytori Therapeutics
Mesoblast Limited
Opexa Therapeutics
Athersys
Geron Corporation
Neostem